Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Berthold Launches Mithras2 Multi-Technology Microplate Reader

Published: Friday, September 27, 2013
Last Updated: Friday, September 27, 2013
Bookmark and Share
Mithras2 LB943 with monochromator and filter technology.

Berthold Technologies has introduced the second generation of its Multimode Microplate Reader Mithras, the Mithras2 LB943 with monochromator and filter technology for these reading technologies
• UV/VIS Absorbance
• Fluorescence and FRET
• Fluorescence Polarization
• Time-Resolved Fluorescence (TRF and TR-FRET)
• Luminescence
• BRET and BRET²
• AlphaScreen® and AlphaLISA®

Already implemented in the TriStar² the patent-pending optical concept ONE-4-ALL is employed for sensitive luminescence, fluorescence and absorbance measurements - with performances as in dedicated instruments - in the Mithras² for filter-based reading.

Additionally the instrument is equipped with two double monochromators with high blocking efficiency and high f-number (increased transmission) for filter-less measurements of absorbance and fluorescence.

For utmost sensitivity in luminescence a third specially selected and extremely noise-reduced detector is engaged in the HiSens position which is used for Alpha and BRET readings, too.

Compared to its predecessor the optics has been improved once again to achieve improved detection limits
• Less than 2 amol ATP per well
• Less than 0.2 fmol Fluorescein per well
• Less than 2 amol Europium per well

Mithras² offers the possibility to use optical filters for luminescence measurements (of course, for all fluorescence and absorbance readings, too) enabling the sensitive measurement of BRET (e.g. functional assays in GPCR research) and multi-coloured luciferases (reporter gene assays).

Each individual filter is coded with an RFID tag and can be positively identified - a significant contribution to correct measurements and to secure quality standards.

Up to 4 reagent injectors with the proven and highly accurate JET technology complete the unit. The injector tips are located in reading position enabling the accurate measurement of very fast reactions.

A new feature is the reagent compartment at the front which keeps the reagents within easy reach and which can be filled with ice to keep them cooled. Reagent mounts hold small reagent containers safely in place and a slight inclination of the mount ensures tubings recover the last droplet.

Cellular assays are taken account of by a universal bottom reading function, a temperature control unit with an incubation compartment for the microplate and gas connectors.

Thus, the Mithras2 is a microplate reader offering comprehensive possibilities and a multitude of applications. The measurement of enzyme activities, phagocytosis, calcium flux, cell viability, apoptosis, immunoassays protein and nucleic acid concentrations and protein-protein interactions are only a few of the manifold fields of application the instrument offers.

The unit is operated with the approved Mikrowin software. Single and multiple endpoint measurements can be performed as well as kinetic and scanning measurements. The data can be displayed numerically and graphically and may be exported to EXCEL or printed.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!